Peripheral IV Infiltration/Extravasation (PIVIE): Reducing Severe Events through Nurse Education and New Technology

Track: 30 Minute Podium

Session Number: 505A
Date: Fri, Apr 26th, 2019
Time: 9:00 AM - 9:30 AM

Description:

1. Helm, R. E., Klausner, J.D., Klemperer, J.D., Flint, L.M., and Huang, E. (2015). “Accepted but Unacceptable: Peripheral IV Catheter Failure.” Journal of Infusion Nursing, 38(3), 189-203.
2. Legemaat, M, et.all, (2016). “Peripheral Intravenous Cannulation: Complication Rates in the Neonatal Population, A Multicenter, Observational Study, Journal of Vascular Access, 17(4) 360-365 3
3. Gorski, Lisa A., et al. “Recommendations for Frequency of Assessment of the Short Peripheral Catheter Site.” Journal of Infusion Nursing, vol. 35, no. 5, 2012, pp. 290–292., doi:10.1097/nan.0b013e318267f636.

Session Type: Quality Improvement

Session Description: Peripheral intravenous (IV) therapy is associated with an overall high failure rate. Current best practice has been unable to correct this problem. Discover how to plan and implement new protocols including immediate countermeasures, education/assessment, and innovative technology for reduction of severe/moderate adverse events from IV infiltration.
Primary Presenter Bio:
Primary Presenter Institution: Children's Hospital of The King's Daughters
Presenter 2 Institution: ivWatch LLC
Presenter 2 Bio: Susan Brown is responsible for the clinical research and training programs for ivWatch as the company’s chief nursing officer. Prior to her position at ivWatch, Susan spent 16 years specializing in pediatric intensive care and ended her tenure in the position of Director, Patient Care Services. During her time at a leading children’s hospital, her responsibilities included managing operational and clinical care departments, including departments responsible for patient flow, vascular access, resource pool, and neonatal/pediatric critical care transport.
Session Type: Quality Improvement

Session Description: Peripheral intravenous (IV) therapy is associated with an overall high failure rate. Current best practice has been unable to correct this problem. Discover how to plan and implement new protocols including immediate countermeasures, education/assessment, and innovative technology for reduction of severe/moderate adverse events from IV infiltration.
Primary Presenter Bio:
Primary Presenter Institution: Children's Hospital of The King's Daughters
Presenter 2 Institution: ivWatch LLC
Presenter 2 Bio: Susan Brown is responsible for the clinical research and training programs for ivWatch as the company’s chief nursing officer. Prior to her position at ivWatch, Susan spent 16 years specializing in pediatric intensive care and ended her tenure in the position of Director, Patient Care Services. During her time at a leading children’s hospital, her responsibilities included managing operational and clinical care departments, including departments responsible for patient flow, vascular access, resource pool, and neonatal/pediatric critical care transport.